Method Development and Validation of Montelukast in Bulk and Pharmaceutical Dosage form by RP-HPLC

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2012, Vol 1, Issue 2

Abstract

The present work describes a simple, precise and accurate HPLC method for estimation of montelukast sodium in bulk and in tablet dosage form. Montelukast sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene (CysLT1) receptor. The separation was achieved by using Waters symmetry shield RP-C8 column and acetonitrile: sodium di-hydrogen Phosphate dehydrate (pH 3.7) in proportion of 70:30 v/v as mobile phase, at a flow rate of 1.5 ml/min. Detection was carried out at 225 nm. The retention time of montelukast sodium was found to be 3.721 min. The limit of detection was found 0.1357 µg/ml and limit of quantification 0.4111 µg/ml. The accuracy and reliability of the proposed method was ascertained by evaluating various validation parameters like linearity (1-30 µg/ml), accuracy, precision, robustness and specificity according to ICH guidelines. The method was statistically validated and RSD was found to be less than 2% indicating high degree of accuracy and precision of the proposed HPLC method. Due to its simplicity, rapidness, high precision and accuracy, the proposed HPLC method may be used for determining Montelukast in bulk or in pharmaceutical dosage forms.

Authors and Affiliations

Minaketan Sahoo*| Institute of Pharmacy and Technology, Salipur, Cuttack, Odisha, India-754202, B V V Ravi Kumar| Roland institute of pharmaceutical sciences, Berhampur, Ganjam,Odisha, N K Tripathy| Dept. of zoology, Berhampur University, Berhampur, Ganjam, Odisha, India, Saroj Kumar Patro| Institute of Pharmacy and Technology, Salipur, Cuttack, Odisha, India-754202

Keywords

Related Articles

Demonstration the Expression of α-Methyl Acyl-Co EnzymeA Racemase, P63 and high- molecular-weight cytokeratin in Prostate biopsies in Khartoum State Hospitals

Prostate cancer is the major health problem throughout the world. PCa remains the most common malignancy affecting men and the second leading cause of cancer-related death of men. The immunohistochemistry plays a very im...

Invention of Analgesic and Anti-Inflammatory Activity of Ethanolic Extract of Mimosa Pudica Linn Leaves.

The ethanolic extract of the leaves of Mimosa pudica at the doses of 200 and 400mg/kg was tested for anti-inflammatory and analgesic activity. The extract produced dose dependent and significant inhibition of carrageen...

Formulation and Evaluation of Pluronic lecithin organogel of Flurbiprofen

The aim of the present work was to generate an index to predict topical ef®ciency of a series of nonsteroidal anti-in¯ammatory drugs Organogel, a viscoelastic system, can be regarded as a semi-solid preparation which has...

INSOMNIA WITH HOMOEOPATHY

Most people encounter sleep difficulties from time to time, often related to stress or pain. Many of these bouts get better without treatment. Unfortunately, in a significant proportion of the population, sleep problems...

DESIGN AND DEVELOPMENT OF SOLID DISPERSION SYSTEM OF ZOLMITRIPTAN

Zolmitriptan is a potent anti-migraine drug. The bioavailability of Zolmitriptan is about 40% via oral dosage forms and problem arises from its low water solubility and dissolution rate. The present study deals with for...

Download PDF file
  • EP ID EP1515
  • DOI -
  • Views 571
  • Downloads 30

How To Cite

Minaketan Sahoo*, B V V Ravi Kumar, N K Tripathy, Saroj Kumar Patro (2012). Method Development and Validation of Montelukast in Bulk and Pharmaceutical Dosage form by RP-HPLC. Journal of Biomedical and Pharmaceutical Research, 1(2), 18-26. https://europub.co.uk/articles/-A-1515